Apollo Completes $750 Million Financing for Mumbai International Airport-July 2024-www.financetom.com

Apollo Completes $750 Million Financing for Mumbai International Airport

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Apollo Completes $750 Million Financing for Mumbai International Airport

Jun 24, 2025 1:12 AM

03:46 AM EDT, 06/24/2025 (MT Newswires) -- Apollo Global Management ( APO ) said late Monday that funds affiliated with the company and long-term investors completed a $750 million financing for the Mumbai International Airport Ltd. in India.

The four-year senior secured notes will mainly refinance existing debt and allow Mumbai International Airport to have the financial flexibility in supporting its operations, modernization and sustainability initiatives.

Mumbai International Airport will also be eligible to receive up to $250 million in additional funding to accelerate capital expenditure and expand capacity, according to Apollo.

Previous page： Novonix Signs Testing, Development Deal With Volkswagen-Owned PowerCo Next page： Update: Arcutis Biotherapeutics Q1 Loss Narrows as Revenue Surges; Shares Soar Premarket

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Novonix Signs Testing, Development Deal With Volkswagen-Owned PowerCo

May 15, 2024

04:32 AM EDT, 05/15/2024 (MT Newswires) -- Novonix ( NVX ) said late Tuesday it signed a non-exclusive testing and development agreement with Volkswagen-owned PowerCo to come up with synthetic graphite anode materials for electric vehicle batteries. The companies could later enter into a supply agreement for the products developed under the deal, Novonix ( NVX ) said. Financial terms...

Update: Arcutis Biotherapeutics Q1 Loss Narrows as Revenue Surges; Shares Soar Premarket

May 15, 2024

04:24 AM EDT, 05/15/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Arcutis Biotherapeutics' ( ARQT ) shares surged more than 20% in premarket activity on Wednesday after the company reported a narrower loss and handily beat market expectations for sales. The company reported a Q1 loss late Tuesday of $0.32 per diluted...

Biogen Partner Eisai Submits FDA Biologics Application for Early Alzheimer's Self-Injection Drug

May 15, 2024

04:26 AM EDT, 05/15/2024 (MT Newswires) -- Biogen (BIIB) and Eisai said Tuesday that the latter has initiated a rolling submission of a biologics license application to the US Food and Drug Administration for lecanemab-irmb subcutaneous autoinjector as a weekly maintenance treatment for early Alzheimer's disease. The application came after the treatment, commercially known as Leqembi, was granted FDA fast-track...

Thyssenkrupp cuts sales, profit forecasts amid gloomy market

May 15, 2024

* Now expects net loss vs break even in 2023/24 * Books impairments on materials trading division * Thyssenkrupp shares -5.7%, Thyssenkrupp Nucera -8% (Adds details on tariff discussion in paragraph) By Christoph Steitz and Tom Käckenhoff FRANKFURT, May 15 (Reuters) - German conglomerate Thyssenkrupp cut its annual forecasts for sales and net profit for the second time in three...